These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 35711082)

  • 1. Non-inferior and more feasible transcutaneous tibial nerve stimulation in treating overactive bladder: A systematic review and meta-analysis.
    Alomari MS; Abdulhamid AS; Ghaddaf AA; Alshareef KM; Haneef AK; AlQuhaibi MS; Banjar RA
    Int J Urol; 2022 Oct; 29(10):1170-1180. PubMed ID: 35711082
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of percutaneous and transcutaneous tibial nerve stimulation in women with idiopathic overactive bladder: A prospective randomised controlled trial.
    Sonmez R; Yildiz N; Alkan H
    Ann Phys Rehabil Med; 2022 Jan; 65(1):101486. PubMed ID: 33429090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of percutaneous and transcutaneous posterior tibial nerve stimulation on idiopathic overactive bladder and interstitial cystitis/painful bladder syndrome: A systematic review and meta-analysis.
    Ghavidel-Sardsahra A; Ghojazadeh M; Rahnama'I MS; Naseri A; Yazdandoost S; Khezerloo T; Seyedi-Sahebari S; Hosseinifard H; Vahed N; Mostafaei H; Salehi-Pourmehr H; Hajebrahimi S
    Neurourol Urodyn; 2022 Feb; 41(2):539-551. PubMed ID: 35032328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment for overactive bladder: A meta-analysis of transcutaneous tibial nerve stimulation versus percutaneous tibial nerve stimulation.
    Yang DY; Zhao LN; Qiu MX
    Medicine (Baltimore); 2021 May; 100(20):e25941. PubMed ID: 34011072
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A single-blind, randomized controlled trial to evaluate the effectiveness of transcutaneous tibial nerve stimulation (TTNS) in Overactive Bladder symptoms in women responders to percutaneous tibial nerve stimulation (PTNS).
    Martin-Garcia M; Crampton J
    Physiotherapy; 2019 Dec; 105(4):469-475. PubMed ID: 30862384
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anticholinergic drugs versus non-drug active therapies for non-neurogenic overactive bladder syndrome in adults.
    Rai BP; Cody JD; Alhasso A; Stewart L
    Cochrane Database Syst Rev; 2012 Dec; 12(12):CD003193. PubMed ID: 23235594
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative Efficacy of Neuromodulation Technologies for Overactive Bladder in Adults: A Network Meta-Analysis of Randomized Controlled Trials.
    Huang J; Fan Y; Zhao K; Yang C; Zhao Z; Chen Y; Yang J; Wang T; Qu Y
    Neuromodulation; 2023 Dec; 26(8):1535-1548. PubMed ID: 35989159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcutaneous tibial nerve electrical stimulation versus vaginal electrical stimulation in women with overactive bladder syndrome: Is there a role for short-term interventions?
    Nunes JMO; Gregório EP; Moreira ECH; Hazime FA; Averbeck MA; de Almeida SHM
    Neurourol Urodyn; 2023 Jun; 42(5):1101-1110. PubMed ID: 37042223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical efficacy of transcutaneous tibial nerve stimulation (TTNS) versus sham therapy (part I) and TTNS versus percutaneous tibial nerve stimulation (PTNS) (part II) on the short term in children with the idiopathic overactive bladder syndrome: protocol for part I of the twofold double-blinded randomized controlled TaPaS trial.
    Ghijselings L; Renson C; Van de Walle J; Everaert K; Spinoit AF
    Trials; 2021 Apr; 22(1):247. PubMed ID: 33810804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bladder training for treating overactive bladder in adults.
    Funada S; Yoshioka T; Luo Y; Sato A; Akamatsu S; Watanabe N
    Cochrane Database Syst Rev; 2023 Oct; 10(10):CD013571. PubMed ID: 37811598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcutaneous Tibial Nerve Stimulation in the Management of Overactive Bladder: A Scoping Review.
    Sayner AM; Rogers F; Tran J; Jovanovic E; Henningham L; Nahon I
    Neuromodulation; 2022 Dec; 25(8):1086-1096. PubMed ID: 35688702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Which anticholinergic drug for overactive bladder symptoms in adults.
    Madhuvrata P; Cody JD; Ellis G; Herbison GP; Hay-Smith EJ
    Cochrane Database Syst Rev; 2012 Jan; 1():CD005429. PubMed ID: 22258963
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of Transcutaneous and Percutaneous Tibial Nerve Stimulation in Bosnian Female Patients with an Idiopathic Overactive Urinary Bladder.
    Zonić-Imamović M; Sinanović O; Imamović M; Muftić M; Janković S; Bazardžanović M
    Acta Med Acad; 2021 Aug; 50(2):235-243. PubMed ID: 34847676
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patient-reported outcomes in the setting of a randomized control trial on the efficacy of transcutaneous stimulation of the posterior tibial nerve compared to percutaneous stimulation in idiopathic overactive bladder syndrome.
    Ramírez-García I; Kauffmann S; Blanco-Ratto L; Carralero-Martínez A; Sánchez E
    Neurourol Urodyn; 2021 Jan; 40(1):295-302. PubMed ID: 33118624
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of tibial nerve stimulation using a wearable device for overactive bladder.
    Liao L; Li X; Chong T; Chen Q; Xu Z; Huang B; Chen M; Li H; Wei Z; Shao Y; Lu J; Pang R; Li X; Wang Y
    BJU Int; 2024 Jun; 133(6):760-769. PubMed ID: 38468422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effectiveness of transcutaneous tibial nerve stimulation (TTNS) for adults with overactive bladder syndrome: A systematic review.
    Booth J; Connelly L; Dickson S; Duncan F; Lawrence M
    Neurourol Urodyn; 2018 Feb; 37(2):528-541. PubMed ID: 28731583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of transcutaneous stimulation of the posterior tibial nerve compared to percutaneous stimulation in idiopathic overactive bladder syndrome: Randomized control trial.
    Ramírez-García I; Blanco-Ratto L; Kauffmann S; Carralero-Martínez A; Sánchez E
    Neurourol Urodyn; 2019 Jan; 38(1):261-268. PubMed ID: 30311692
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Percutaneous tibial nerve stimulation for overactive bladder syndrome: a systematic review and meta-analysis.
    Wang M; Jian Z; Ma Y; Jin X; Li H; Wang K
    Int Urogynecol J; 2020 Dec; 31(12):2457-2471. PubMed ID: 32681345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Percutaneous tibial nerve stimulation versus tolterodine for overactive bladder in women: a randomised controlled trial.
    Preyer O; Umek W; Laml T; Bjelic-Radisic V; Gabriel B; Mittlboeck M; Hanzal E
    Eur J Obstet Gynecol Reprod Biol; 2015 Aug; 191():51-6. PubMed ID: 26073262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Percutaneous tibial nerve stimulation versus sham efficacy in the treatment of refractory overactive bladder: outcomes following a shortened 6-week protocol, a prospective randomized controlled trial.
    Lashin AM; Eltabey NA; Wadie BS
    Int Urol Nephrol; 2021 Dec; 53(12):2459-2467. PubMed ID: 34601705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.